Stocks

Pharma Stock Market Review

Latest Pharma Stock Updates

decorative

Valneva Stock Price Drops 40% as UK cancels vaccine deal

Valneva shares dropped by around 40% in early trading on Monday as the UK government announced its intention to withdraw

covid shares

Covid Vaccine Shares Hit by US Administration Decision to Wave Patents

The announced temporary waiver of COVID-19 vaccine patents by Joe Biden’s administration has hit vaccine maker shares and raised serious

decorative

Evotec Invests in Oxford University Spinout Cell Therapy Company OxVax

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) revealed that it has invested in OxVax, a new immuno-oncology organization

drug resistant bacteria

Phico Therapeutics Awarded up to $18.2 Million Funding to Advance Antibacterial Therapy

Phico Therapeutics (‘Phico’), a British biotech company developing engineered phage technologies as the foundation of a new wave of antibiotics

Thermo Fisher to Acquire CRO giant PPD for $17.4 Billion in Cash

Thermo Fisher Scientific expands clinical research service offering to pharma and biotech customers with a CRO giant PPD acquisition. Thermo

Evotec Launches the First Translational BRIDGE in Germany in Collaboration with Bristol-Myers

Evotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $

Phenomic AI starts with $6M using AI/ML for Targeting the Tumor Stroma

Phenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6

letter of intent

Enzolytics and BioClonetics intent to merge sends stock parabolic

Enzolytics, Inc, a drug development company with a focus on debilitating infectious diseases, announced on September 16, the execution of

cardiovascular disease

BMS boosts cardiovascular pipeline with $13.1 Billion MyoKardia buy

Bristol Myers Squibb is strengthening its cardiovascular pipeline through a $13.1 Billion acquisition of biotech firm MyoKardia. The $13.1 Billion

Biotech firms raise $12.6B investment in H1 of 2020

Biotechnology has spearheaded the healthcare industry in investment action from private equity and venture capital during the first half of

Advertisement